triple hormone receptor agonist retatrutide for obesity 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase 3 Trial New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide Explained: How the Triple
Description
Acta Neuropsychiatr 37: e50
Large outcome trials such as SELECT and FLOW have shown 20 percent reductions in cardiovascular and kidney complications in high-risk adults
It is controversial between drugs in treating PPHG
doi: 10.1186/s40168-024-01975-x
Plus, while there are similar drugs like tirzepatide (Zepbound), theres currently no generic version of the medication available
